Lanzamiento Enero 2027

Ensayo controlado aleatorizado1999Financiación no declarada

Long-term efficacy and safety of a new olive oil-based intravenous fat emulsion in pediatric patients: a double-blind randomized study

Goulet O, de Potter S, Antébi H, Driss F, Colomb V, Béréziat G, Alcindor LG, Corriol O, Le Brun A, Dutot G, Forget D, Perennec V, Ricour C

The American journal of clinical nutrition · 80 citas

Etiquetas de revisión

Financiación no declarada

Datos neutrales que nuestra revisión registró sobre cómo se hizo este estudio. Describen el método, nunca si nos gusta el resultado.

Cómo se estudió

Diseño
Ensayo controlado aleatorizado (indexado por PubMed)
Estudiado en
Personas
Resultado principal
Marcadores de salud y funcionamiento
Consumo medido con
No se indica

Quién lo pagó

Financiación
Financiación no declarada

Publicación

Publicado
1999-09-01 · Am J Clin Nutr · vol. 70 · número 3 · págs. 338–345
Editorial
Elsevier BV
Citado
132 citas · más que el 88% de estudios similares · 2.3× el promedio de su campo
Referencias
67 trabajos
Acceso
Lectura gratuita
Áreas de investigación
Clinical Nutrition and Gastroenterology · Fatty Acid Research and Health · Central Venous Catheters and Hemodialysis
Palabras clave
pediatric parenteral nutrition, long-chain triglycerides, monounsaturated fatty acids, polyunsaturated fatty acids, erythrocyte membrane fatty acid composition, lipid peroxidation, cholesterol, apolipoproteins
MeSH
humans, dietary fats, unsaturated, fat emulsions, intravenous, plant oils, parenteral nutrition, double-blind method, child, child, preschool, infant, female, male, olive oil

13 autores

  • Olivier Goulet🇫🇷 · autor de correspondenciaHôpital Necker-Enfants Malades; Hôpital Saint-Antoine
  • Sophie De Potter🇫🇷Hôpital Necker-Enfants Malades; Hôpital Saint-Antoine
  • H. Antébi🇫🇷Hôpital Necker-Enfants Malades; Hôpital Saint-Antoine
  • Fathi Driss🇫🇷Hôpital Necker-Enfants Malades; Hôpital Saint-Antoine
  • V. Colomb🇫🇷Hôpital Necker-Enfants Malades; Hôpital Saint-Antoine
  • Gilbert Bereziat🇫🇷Hôpital Necker-Enfants Malades; Hôpital Saint-Antoine
  • Louis‐Gérald Alcindor🇫🇷Hôpital Necker-Enfants Malades; Hôpital Saint-Antoine
  • Odile Corriol🇫🇷Hôpital Necker-Enfants Malades; Hôpital Saint-Antoine
  • Alexia Le Brun🇫🇷Hôpital Necker-Enfants Malades; Hôpital Saint-Antoine
  • Guy Dutot🇫🇷Hôpital Necker-Enfants Malades; Hôpital Saint-Antoine
  • Dominique Forget🇫🇷Hôpital Necker-Enfants Malades; Hôpital Saint-Antoine
  • V. Pérennec🇫🇷Hôpital Necker-Enfants Malades; Hôpital Saint-Antoine
  • C. Ricour🇫🇷Hôpital Necker-Enfants Malades; Hôpital Saint-Antoine

Resumen

El texto original del estudio, en el idioma en que se publicó.

Background

A new intravenous lipid emulsion (ILE) prepared from a mixture of soybean and olive oils contains only long-chain triacylglycerols, with a low proportion (20%) of polyunsaturated fatty acids and 60% monounsaturated fatty acids.

Objective

The goal of this randomized, double-blind clinical trial was to assess in children the efficacy and safety of this new ILE compared with a control group receiving a soybean-oil emulsion.

Design

Eighteen children received for 2 mo 24% of nonprotein energy (1.80 g kg (-)(1) d(-)(1)) either as the new ILE or a soybean oil-based emulsion. Assessments were performed on days -30, 0, 30, and 60 and the changes (day 60 - day 0) assessed by analysis of variance.

Results

There were no significant differences in triacylglycerol, apolipoproteins A-I and B, or HDL cholesterol between the 2 groups, whereas total and LDL cholesterol were higher in the soybean oil group on day 60. The pattern of 20:4n-6 in erythrocyte membranes did not change significantly, nor did the ratio of 20:3n-9 to 20:4n-6. On day 60, 18:1n-9 was significantly higher in the olive oil group, the ratio of Sigma(n)-6 > C(18) + 18:3n-6 to 18:2n-6 was 2.20 +/- 0.09 in the olive oil group and 1.33 +/- 0.16 in the soybean-oil group, and Sigma(n)-3 > C(18) was 3.83 +/- 0.30 in the olive oil group and 4. 03 +/- 0.33 in the soybean-oil group. The peroxidation index was lower after the olive oil treatment.

Conclusions

The olive oil-based emulsion was well tolerated, maintained a normal EFA status, and may be more suitable for prevention of lipid peroxidation than the soybean-oil-based emulsion.

Resumen vía Europe PMC. Los derechos de autor siguen siendo de los autores o la editorial.

Confianza de la comunidad

Cargando…

¿Cuánto confías en los hallazgos de este estudio?

0 · nada10 · totalmente

Comentarios

¿Algo está mal aquí?

Señala este estudio si su información, etiquetas o financiación parecen incorrectas. Un editor revisa cada señalamiento.

Información educativa sobre investigación publicada. No es consejo médico ni una recomendación para empezar o dejar nada.